Prostate cancer differentiation, DiaPat PCa status test

PCa status test

About 45% of patients initially diagnosed with prostate cancer have only a slow-growing form of cancer. In this case, 'active surveillance' is a good idea, so that only patients with aggressive prostate cancer can be operated on. However, this means that biopsies are always necessary. The DiaPat® PCa Status test helps to avoid frequent, invasive biopsies and to detect malignant prostate cancer with high accuracy.

• Active surveillance of prostate cancer
  
• Collect urine sample - simple + discreet
• CE-compliant laboratory diagnostics
• High analytical accuracy
• Clinically proven
• Result within 2-3 working days after sample receipt